Amneal Pharmaceuticals, Inc.
AMRX
$7.48
$0.060.81%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -39.16% | -1,886.83% | -8,426.17% | -25.17% | 35.38% |
| Total Depreciation and Amortization | 2.96% | -2.80% | -5.33% | -5.71% | -4.49% |
| Total Amortization of Deferred Charges | 151.97% | -18.51% | -5.54% | 15.61% | 34.36% |
| Total Other Non-Cash Items | -36.06% | 38.58% | 62.51% | 828.94% | 3,666.30% |
| Change in Net Operating Assets | 91.38% | 111.77% | 74.59% | -101.43% | 21.28% |
| Cash from Operations | -14.61% | 67.78% | 27.09% | 138.50% | 430.84% |
| Capital Expenditure | -28.93% | -6.87% | 12.61% | 4.32% | 4.09% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 34.56% | -1,264.55% | 5.82% | 22.82% | 45.13% |
| Cash from Investing | 8.95% | -60.59% | 15.83% | 12.90% | 60.31% |
| Total Debt Issued | -89.01% | 240.67% | 284.73% | 145.29% | 413.80% |
| Total Debt Repaid | 43.70% | -160.19% | -182.01% | -117.48% | -235.91% |
| Issuance of Common Stock | 155.88% | 156.37% | 97.87% | -13.07% | -31.87% |
| Repurchase of Common Stock | -234.40% | -234.24% | -233.59% | -191.98% | 33.41% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 91.48% | -146.18% | -372.42% | -520.21% | -256.51% |
| Cash from Financing | 0.37% | -87.76% | -162.86% | -284.52% | -99.37% |
| Foreign Exchange rate Adjustments | -1,636.92% | 98.50% | 90.78% | 74.07% | 101.14% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -69.77% | -5,978.17% | -496.10% | -51.89% | 128.84% |